Regencell Bioscience Holdings Limited Shareholders' Equity
Regencell Bioscience Holdings Limited (RGC) had Shareholders' Equity of $4.86 million as of 2025-06-30, per its 20-F filed 2025-10-31.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-10-31
- 2025-06-30: Stockholders' Equity Attributable to Parent $4.86M.
- 2024-06-30: Stockholders' Equity Attributable to Parent $8.22M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $12.03M.
- 2022-06-30: Stockholders' Equity Attributable to Parent $17.07M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-06-30 | $4.86M 20-F · filed 2025-10-31 |
| 2024-06-30 | $8.22M 20-F · filed 2025-10-31 |
| 2023-06-30 | $12.03M 20-F · filed 2024-10-25 |
| 2022-06-30 | $17.07M 20-F · filed 2023-10-27 |
| 2021-06-30 | -$4.00M 20-F · filed 2022-10-31 |
| 2020-06-30 | -$2.65M 20-F · filed 2021-10-29 |
| 2019-06-30 | -$1.84M 20-F · filed 2021-10-29 |
| 2018-06-30 | -$1.45M 20-F · filed 2021-10-29 |